SBFM - MCAP CO - Sunshine Biopharma

The stock price trend for Sunshine Biopharma (SBFM) on the GURU.Markets platform reflects the dynamics of an asset whose revenue is based on bringing breast cancer and antiviral drugs to market. The current indicator is 0.00. Sunshine Biopharma (SBFM) combines the production of generic drugs with scientific research to combat resistant tumors. Meanwhile, amid unstable revenues and a need for investment, management is adjusting its medical plans.

The market capitalization of Sunshine Biopharma (SBFM) is calculated as the product of the current share price and the total number of outstanding securities. This aggregator measures the total value of the business, reflecting market confidence in the issuer's assets. For Sunshine Biopharma, this metric depends directly on the efficiency of climate regulation compliance during the delivery of oncology drugs. Stable logistics chains minimize the risks of medication degradation. By analyzing the company's public capitalization chart, an investor can assess the fundamental stability of the business.